These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 10395030

  • 1. Reversal by [D-Ala2,D-Leu5]enkephalin of the dopamine transporter loss caused by methamphetamine.
    Tsao LI, Cadet JL, Su TP.
    Eur J Pharmacol; 1999 May 21; 372(3):R5-7. PubMed ID: 10395030
    [Abstract] [Full Text] [Related]

  • 2. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.
    Hayashi T, Hirata H, Asanuma M, Ladenheim B, Tsao LI, Cadet JL, Su TP.
    Synapse; 2001 Mar 15; 39(4):305-12. PubMed ID: 11169780
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [D-Ala2, D-Leu5]enkephalin blocks the methamphetamine-induced c-fos mRNA increase in mouse striatum.
    Hayashi T, Tsao LI, Cadet JL, Su TP.
    Eur J Pharmacol; 1999 Feb 05; 366(2-3):R7-8. PubMed ID: 10082218
    [Abstract] [Full Text] [Related]

  • 8. A rapid and reversible change in dopamine transporters induced by methamphetamine.
    Fleckenstein AE, Metzger RR, Gibb JW, Hanson GR.
    Eur J Pharmacol; 1997 Apr 04; 323(2-3):R9-10. PubMed ID: 9128855
    [Abstract] [Full Text] [Related]

  • 9. Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine.
    Sandoval V, Hanson GR, Fleckenstein AE.
    Eur J Pharmacol; 2000 Dec 15; 409(3):265-71. PubMed ID: 11108820
    [Abstract] [Full Text] [Related]

  • 10. Chronic [D-Ala2, D-Leu5]enkephalin treatment increases the nerve growth factor in adult mouse brain.
    Hayashi T, Su TP.
    Eur J Pharmacol; 2003 Mar 19; 464(2-3):237-9. PubMed ID: 12620518
    [Abstract] [Full Text] [Related]

  • 11. Methamphetamine-induced decrease in tryptophan hydroxylase activity: role of 5-hydroxytryptaminergic transporters.
    Fleckenstein AE, Beyeler ML, Jackson JC, Wilkins DG, Gibb JW, Hanson GR.
    Eur J Pharmacol; 1997 Apr 18; 324(2-3):179-86. PubMed ID: 9145769
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.
    Scheffel U, Steinert C, Kim SE, Ehlers MD, Boja JW, Kuhar MJ.
    Synapse; 1996 Jun 18; 23(2):61-9. PubMed ID: 8723710
    [Abstract] [Full Text] [Related]

  • 19. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.
    Frey K, Kilbourn M, Robinson T.
    Eur J Pharmacol; 1997 Sep 10; 334(2-3):273-9. PubMed ID: 9369358
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.